⌘K

Login Start Free

Home/Filings/4/0000899243-21-049172

4//SEC Filing

Pienta Kenneth 4

Accession 0000899243-21-049172

CIK 0001645460other

View on SEC.gov Company Profile

Filed

Dec 20, 7:00 PM ET

Accepted

Dec 21, 4:05 PM ET

Size

5.4 KB

Accession

0000899243-21-049172

Insider Transaction Report

Form 4

Period: 2021-12-20

Cue Biopharma, Inc.CUE

Chief Medical Officer

Transactions

Award
Stock Option (right to buy)
2021-12-20+80,000→ 80,000 total
Exercise: $11.45Exp: 2031-12-20→ Common Stock (80,000 underlying)

Footnotes (1)

[F1]This stock option grant becomes exercisable in four equal semi-annual installments beginning June 20, 2022.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Cue Biopharma, Inc.

CIK 0001645460

Entity typeother

Related Parties

1

filerCIK 0001571862

Filing Metadata

Form type: 4
Filed: Dec 20, 7:00 PM ET
Accepted: Dec 21, 4:05 PM ET
Size: 5.4 KB

View on SEC.gov